In the manufacture of budesonide enteric capsules, pellet coating establishes the foundation for targeted drug delivery.
The enteric coating of hard capsules, however, represents the final protective barrier, ensuring that the dosage form passes safely through the gastric environment and reaches the intended intestinal site.
In industrial practice, questions frequently arise:
These issues are closely linked to the uniformity and process stability of hard capsule enteric coating.
Related articles:
– Budesonide Enteric Capsules (Part I): Fluid-Bed Drug Layering and Coating Analysis
– Budesonide Enteric Capsules (Part II): Micro-Pellet Filling & Hard Capsule Sealing Explained
Compared with conventional enteric-coated tablets, enteric-coated hard capsules offer greater formulation and process flexibility.
They are particularly suitable for APIs such as budesonide, which are sensitive to compression or require complex release profiles.

Micronized budesonide is dispersed in a hydroxypropyl methylcellulose (HPMC) solution to prepare a drug-layering suspension. The suspension is layered onto sugar pellet cores, resulting in drug-loaded pellets.
Citric acid and hydroxypropyl methylcellulose are formulated into a seal coating solution.
The seal coating is applied to the drug-loaded pellets to obtain sealed pellets, providing protection for the drug layer and preparing the surface for subsequent functional coatings.
A sustained-release coating dispersion is prepared by blending hydroxypropyl methylcellulose, an aqueous polyethylene glycol solution, and ethylcellulose aqueous dispersion (Surelease®, Type B).
The coating is layered onto the sealed pellets and cured to form sustained-release pellets.
The sustained-release pellets are filled into size 1 hydroxypropyl methylcellulose (HPMC) hard capsules.
The filled capsules are enteric-coated using a blended system of methacrylic acid–methyl methacrylate copolymers in ratios of 1:1 and 1:2 (EUDRAGIT® L 100 and EUDRAGIT® S 100), resulting in budesonide enteric capsules.
Source: Patent CN120053463A
Taking Nefecon® (marketed as TARPEYO®) as an example:
This dual-release design — delayed capsule opening combined with sustained pellet release — is essential for achieving localized therapeutic action with minimal systemic side effects.
Non-uniform coating is a primary cause of inconsistent release behavior in enteric-coated capsules.
In industrial manufacturing, coating uniformity can be evaluated at two levels:
Insufficient control of coating uniformity may result in:
Coating uniformity is influenced by multiple interacting factors, including capsule size and geometry, pan rotation speed, batch load, pan design, and baffle configuration.

To address the coating challenges associated with budesonide capsules, Canaan BGX Series High-efficiency Coater is engineered around three critical process elements, providing stable and reliable performance for enteric capsule coating.
Based on the physical properties of hard capsules, Canaan applies customized multi-configuration impellers. Through optimized blade angles, capsules undergo radial movement combined with axial turnover, generating a three-dimensional convective flow pattern and ensuring uniform coating without dead zones.



During capsule coating, as the coating weight increases, the bed height rises and the distance between the capsules and the spray guns decreases.
Such changes may lead to variations in droplet distribution and coating uniformity.
Canaan BGX Series Coater is equipped with an automated spray gun adjustment mechanism, which dynamically regulates the height and angle of the spray guns during operation.
This ensures stable atomization conditions throughout the process and prevents non-uniform coating caused by distance variation.
The system is operated via the TechproM V4 control platform, which integrates digital process control with real-time sensing to achieve precise closed-loop regulation of critical parameters:
Negative Pressure: ±10 Pa
Temperature: ±1 °C (up to ±0.5 °C under stable steam conditions)
Humidity: ±0.5 g/kg
Airflow: ±3 %
Combined with internationally recognized control valve components, the system significantly reduces the risk of coating defects such as powder loss, sticking, and orange peel formation.
Canaan Solid Dosage Form R&D Center is equipped with a complete platform ranging from small-scale trials to pilot-scale production, providing customers with:
The manufacture of budesonide enteric capsules represents a highly coordinated process chain, spanning pellet coating → capsule filling → capsule coating.
Leveraging extensive expertise and accumulated case experience in solid dosage form equipment, Canaan has supported multiple pharmaceutical manufacturers from laboratory trials to full-scale production lines.
Canaan continues to collaborate with pharmaceutical partners to overcome challenges in high-end solid dosage form industrialization, ensuring that precision drug delivery is not only designed, but reliably manufactured.
Welcome to Canaan Solid Dosage Form R&D Center to observe budensonide capsule coating trials firsthand.





Batch-to-batch variability and low tablet production yields remain persistent challenges in solid dosage manufacturing. When inconsistencies arise, manufacturers often focus on excipient selection or process parameter adjustments. In many cases, the underlying issue is in the selection of the granulation process itself. This article explores Canaan’s granulation solutions for different material characteristics and process requirements, […]

Quick Answer Continuous manufacturing pharmaceutical systems merge blending, granulation, and compression into one unbroken line to meet GMP compliance under 21 CFR Part 11. These lines run in-line, real-time quality monitoring instead of end-of-batch testing, typically handling 5 to 40 kg per hour. Canaan’s integrated pharmaceutical continuous manufacturing lines are built to meet these standards, […]

Quick Answer Cleaning validation in pharmaceutical manufacturing is the documented proof that equipment meets a set residue limit every time. A validated wash runs pre-rinse, detergent wash, rinse, and dry stages under fixed time, temperature, and pressure parameters. Canaan’s QD Series washing stations combine automated washing and drying in one controlled cycle, with key process […]